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Abstract
Background: Canine cancer registry data can be put to good use in epidemiological studies. Quantitative
comparison of tumour types may reveal unusual cancer frequencies, providing directions for research and
generation of hypotheses of cancer causation in a specific area, and suggest leads for identifying risk factors. Here
we report canine cancer incidence rates calculated from a population-based registry in an area without any known
specific environmental hazard.
Results: In its 90 months of operation from 2001 to 2008 (the observation period in this study), the population-
based Piedmont Canine Cancer Registry collected data on 1175 tumours confirmed by histopathological diagnosis.
The incidence rate was 804 per 100,000 dog-years for malignant tumours and 897 per 100,000 dog-years for benign
tumours. Higher rates for all cancers were observed in purebred dogs, particularly in Yorkshire terrier and Boxer. The
most prevalent malignant neoplasms were cutaneous mastocytoma and hemangiopericytoma, and mammary
gland complex carcinoma and simplex carcinoma.
Conclusions: The Piedmont canine cancer registry is one of few of its kind whose operations have been
consistently supported by long-term public funding. The registry-based cancer incidence rates were estimated with
particular attention to the validity of data collection, thus minimizing the potential for bias. The findings on cancer
incidence rates may provide a reliable reference for comparison studies. Researches conducted on dogs, used as
sentinels for community exposure to environmental carcinogens, can be useful to detect excess risks in the
incidence of malignant tumours in the human population.
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Background
Canine cancer registry data can be put to good use in
epidemiological studies. Quantitative comparison of
tumour types may reveal unusual cancer frequencies,
providing direction for research and generation of hy-
potheses of cancer causation in a specific area, and sug-
gest leads for identifying risk factors.
The pivotal role of the sentinel animal some species
play at a low level in the trophic chain, e.g., to show the
effect of endocrine disruptors, [1] could also be assumed
by dogs. The existence of a tumour registry in this spe-
cies can pinpoint variations in cancer incidence in target
organs. One task of such registries is to determine
whether potential correlations exist between an increase
or decrease in cancer incidence and environmental haz-
ards. In a study conducted 25 years ago on companion
animals as a sentinel for environmentally related human
diseases, a correlation was found whereby changes in the
canine proportionate incidence ratios preceded human
incidence rates by 2 years, suggesting that fluctuations in
proportionate incidence ratios of tumours in dogs may
be useful for predicting changes in cancer patterns in
humans [2]. Because these variations can only be dis-
cerned when the size of an observed population is
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known, and knowledge of the animal population size of
a specific area is required for estimating the incidence of
zoonotic diseases [3], veterinary epidemiologists face nu-
merous hurdles to arriving at a correct estimate of an
animal population at risk.
To get around this problem, some registries have ob-
tained the denominator from pet insurance company da-
tabases [4, 5], but with the risk of having an incomplete
denominator and introducing a systematic error. Insured
dogs likely represent a selected subset of the real com-
position of an area’s dog population. [6]. Recognizing
this limitation, veterinary studies have underscored the
importance of selecting a delimited geographic area as
referential for case collection when establishing animal
population-based tumour registries. After an area has
been selected, a distinction is made between cases be-
longing to the area and those not belonging to it. Cases
belonging to the area but diagnosed outside of it then
need to be identified and retrieved, and cases of animals
living outside of it need to be excluded. It is acknowl-
edged that the owners of dogs with cancer will often use
veterinary services whereby cases are detected and re-
ported, ultimately restricting the denominator to dogs
receiving veterinary care.
The first population-based canine tumour registry was
set up by the California State Department of Public
Health to estimate the cancer incidence in dogs and cats
resident in two counties in California, and to measure
the effects of age, sex and breed on cancer development
[7]. Over a 3-year period, malignant neoplasm cases in
dogs and cats were reported to the registry through the
collaboration of county veterinarians. The cases were
categorized by their primary tumour site according to
the International Classification of Diseases, Revision 7
(ICD-7). The estimated annual incidence rates for malig-
nant cancers of all anatomic sites were 381.2/100,000
dogs and 155.8/100,000 cats.
Ten years later, MacVean et al. [8] investigated the de-
nominator for the cancer incidence rate for dogs seen by
veterinarians in one year in two counties. Histopatho-
logical diagnosis was offered free to the practitioners
participating in the registry. The annual incidence rate
for malignant neoplasms was 507/100,000 dogs, or
double that of the Californian registry. Other European
studies, using as denominator the cynological organization
databases, reported incidence rates for some specific
breeds [9–11].
The results of two cancer registration projects in Italy
have recently been published. The Animal Tumour
Registry of Genoa estimated an incidence rate for malig-
nant cancers of 185.7/100,000 dogs [12]. The Animal
Tumour Registry of Venice and Vicenza counties was
set up in 2005 and provides free histopathological testing
to veterinary practices in its catchment area. The
estimated incidence rate for malignant neoplasms was
142.8/100,000 dogs [13].
Here we report canine cancer incidence data collected
between 2001 and 2008 for a small, well-delimited geo-
graphical area in northwestern Italy. As the data were
obtained from a population-based registry, the Piedmont
Canine Cancer Registry, for an area without any known
specific environmental hazard, they may be considered a
reliable estimate of reference incidence rates and so may
serve as comparison data for other registries.
Methods
Denominator
The catchment area was selected according to the fol-
lowing criteria: 1) a population of less than 20,000 dog
units with an annually expected number of suspected
cases bearable by the histopathological laboratory (the
bearable burden of diagnostic testing was calculated
using as “expected incidence” the figures reported in
Dorn et al. [7] in their population-based registry in
California); 2) both urban and rural environments to
allow internal comparisons within the dataset; 3) a geo-
graphically well-delimited area.
Based on the above criteria, an area (Fig. 1) comprising
46 municipalities in northernwestern Piedmont was se-
lected, where 17,770 dogs were recorded in the canine
identification and registration system, which at the time
(2001) was still in hard copy format. The area is under
the administration of a single local health unit. It is bor-
dered to the west and north by geographical barriers
(Alps); on its southern and eastern borders it is sur-
rounded by municipalities within the same local health
unit that acted as a buffer area for data collection. The
22 veterinary practitioners in the catchment area and
the buffer area were involved in the collection and iden-
tification of suspected tumours. The ArcGIS version 9.2
(ESRI, Redlands, CA, USA) was used to create the the-
matic map.
Surveys were carried out to estimate the real size of
the dog population, removing the deceased subjects and
including the unregistered dogs within the local canine
identification and registration systems.
A capture-recapture (CR) method (Lincoln Petersen)
[14] - normally used in ecology - was adopted and ap-
plied to the canine population of the catchment area.
The CR method has been already applied to define the
reference animal population in cancer registries [13] and
is routinely used in epidemiological studies. The first
stage of the method is the capture of a number of indi-
viduals (M), marked, and subsequently released within
the general population.
In a second stage, a new random sample (n) is cap-
tured, out of which (m) is found to be already marked. If
the marked subjects perfectly merge with the unmarked
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animals, the proportion of the marked individuals within
the unknown overall population N and within the sec-
ond sample n remains constant: m / n = M / N.
In this study, the first ‘capture’ is represented by the
data from the regional canine identification and registra-
tion system, corrected after excluding the deceased sub-
jects. This preliminary correction was carried out on the
basis of a pilot telephone survey of the dog owners. The
sample size of the survey (n = 545) was calculated on
the basis of an expected prevalence rate of 15% of de-
ceased dogs, an error of 3%, a 95% confidence interval
(CI), and an expected response rate of 80%. The sample
was stratified according to the number of dogs registered
per municipality. The second random sample (recapture)
was obtained by means of an anonymous questionnaire
survey to estimate the proportion of unregistered dogs
and, therefore, the overall population; the sample size
was calculated using the same parameters (expected
prevalence 15%, accepted error 3%, 95% CI). Moreover,
the second survey was also used to estimate the
structure of the canine population by age, sex, and
breed and to estimate the proportion of owned dogs
receiving veterinary care. The latter data were needed
to estimate the proportion of the dog population that
was actually seen in veterinary practices and could
provide the incident cases to the laboratory. In urban
areas the questionnaires were distributed in public of-
fices (exam reservation centres), whereas in rural
areas through the collaboration of the post office ser-
vices which served also as questionnaire collection
sites: 2000 hard copies of the questionnaire were
printed out and distributed.
Fig. 1 The catchment area of the canine tumour registry. Left angle: map of Italy and Piedmont; Right angle: map of Piedmont and the
catchment area
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Finally, a dog population census based on 28,068 ques-
tionnaires sent to each household and covering most (44
out of 46) of the involved municipalities was conducted
in 2005, four years after the start of the registration, by
the local official veterinary service and used to validate
and update the capture-recapture estimates.
Numerator
A parallel public awareness campaign was launched
through announcements in local print and media chan-
nels to inform dog owners about the canine tumour
registry and its services. The tumour samples collected
by biopsy, post-mortem or surgical removal were sent to
the two diagnostic laboratories participating in the pro-
ject and analysed free of charge. In addition, a dissection
room was set up by the official veterinary service of the
area for post-mortem examination and cancer detection
if the owner decided to have the dog euthanised.
All veterinary practices were provided with a stan-
dardised case report form specifically designed for the
collection of canine cancer cases. Because very few
dogs had a subcutaneous microchip carrying their
identification number, the animal’s name, breed, date
of birth, sex, and the owner’s surname and address of
the place of residence were recorded to identify each
animal. Where the breed was not clearly indicated or
two breeds were reported as indication of a mixed
breed, this was included in the category “crossbreed”.
Tumour data included anatomic site, lesion size, date
of excision, and any related historical and clinical in-
formation (e.g., ovariohysterectomy or castration status).
The participating practitioners were also provided with a
form to report cases in which cancer diagnosis had been
obtained from laboratories other than the two project
laboratories.
Formalin-fixed samples were routinely processed,
paraffin-embedded and stained with haematoxylin and
eosin for histological examination. Immunohistochemi-
cal analysis was performed to characterise poorly differ-
entiated neoplasms. Tumours were classified and coded
according to the Classification of tumours of domestic
animals, World Health Organization Tumor Fascicles
and the International Classification of Diseases for
Oncology, 3rd edition (ICD-0) [15–17].
Based on the histopathological diagnosis, each type of
neoplasm of a multiple primary tumours was classified
as a separate cancer and added to the numerator
Cancer incidence calculation
A database (Microsoft Access) was created for collecting
all cancer cases: information about sex, age, place of
residence, veterinarian, number of tumours in the same
dog, tumour classification, and tumour behaviour were
entered into the database.
Incidence rates were calculated for histologically
assessed malignant and benign tumours. In particular,
specific rates by age, breed and sex were estimated with
95% confidence intervals. The incidence rates were
expressed as the number of cases per 100,000 dog-years.
A rate ratio was calculated to compare two subsequent
registration period and its 95% confidence level was cal-
culated to detect an eventual statistical significant differ-
ence (i.e. in case the 95% confidence interval would not
include a value of 1). Statistical data analysis was
performed using STATA software SE 11 (Stata Corp.,
College Station, TX, USA).
Results
Dog population size and structure
When the registration activity started in 2001, the ref-
erence canine population was estimated through a
capture-recapture approach that yielded an overall
population of 10,095 dogs (95% confidence interval
(CI) 9705–10,485). As the first capture was based on
dogs registered with the local identification and regis-
tration systems, 590 telephone interviews with dog
owners were conducted (87% response rate) to prelim-
inarily estimate the proportion of deceased dogs still
registered. About half (55%) of the registered dogs had
already died; therefore, the number of dogs registered
and still alive (first capture) was estimated to be 8005.
The second capture was obtained through an anonym-
ous questionnaire survey (31.35% response rate) that
yielded the identification of 627 dogs, 497 of which
(79.3%) were recaptured as already registered with the
canine registry office (95% CI 75.8–82.3). A 2005 mid-
term census of the municipalities in the catchment
area (44 out of 46) confirmed the previous population
estimates: the canine population was 9987 dogs as
compared to the 9097 dogs estimated in the same 44
municipalities with the capture-recapture method (with
a potential underestimation of 9.6%). Owing to the in-
completeness of the census data (one of the two mu-
nicipalities excluded was the largest town in the area),
only the capture-recapture estimates were used as de-
nominators for computing the incidence rates.
In the second survey, 91% of dog owners reported that
they regularly used veterinary services for their dog’s
health care (95% CI 88–93), suggesting that the veterin-
ary practitioners were able to find tumours in 9182 dogs
out of the 10,095 calculated. Based on the population
size and the observation period (90 months), the total
dog-years of observation to calculate the incidence rates
were 68,865. In all, 55% of the dogs were male (95% CI
51–59%) and 48% were purebred (95% CI 44–52%), with
23 pure breeds (mainly German shepherd dog, Boxer,
Yorkshire terrier, English setter and Siberian husky).
Figure 2 shows the population structure by age.
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Numerators and incidence rates
In its 90 months of operation, the Piedmont Canine
Cancer Registry collected data on 1172 tumours, of
which 618 benign and 554 malignant tumours were con-
firmed by histopathological diagnosis. Figure 3 presents
the distribution of cases by most frequent tumour site.
The crude incidence rate was 804 per 100,000 dog-
years for malignant tumours and 897 per 100,000 dog-
years for benign tumours. As there was a decreasing
trend for cancer cases at the end of 2002, we also calcu-
lated the incidence rates after splitting the registration
period into two parts, before and after 01 June 2003
(period 1 vs. period 2); no statistically significant differ-
ence in the rates of malignant tumours was found (rate
ratio [RR] 1.09, 95% CI 0.89–1.31) (Table 1).
Overall, the higher cancer incidence rates in the fe-
male dogs were largely due to the high number of mam-
mary tumours.
Higher incidence rates for all cancers were observed in
purebreds. The incidence rates by breed are presented in
Table 2. The most common breeds in the study popula-
tion were the German shepherd dog (7785 dog-years),
the Italian segugio (2003 dog-years), the English setter
(1335 dog-years), and the Maremma sheepdog (1335
dog-years).
The cancer rates by age class in male and female dogs
were similar up to the biennial class of 4–5.9 years, after
which the rates started to diverge, with an increase
noted for the females and a decrease for the males after
the 10–11.9 age class (Fig. 4). The distribution of malig-
nant tumours by sex and tumour site is shown in Fig. 5.
The most commonly affected organs were the mam-
mary gland (n = 585), skin (n = 229), and ovaries
(n = 40) in the female dogs and the skin (n = 242), testi-
cles (n = 112), and spleen in the male dogs.
Table 3 reports the incidence rates of tumours by
histological type and organ of origin (cases per 100,000
dog-years at risk) in the most frequently affected sites.
Discussion
Here we present the findings obtained from a canine
population-based cancer registry that we conducted in
northwestern Italy for a 90-month period from 2001 to
2008. The Piedmont canine cancer registry is one of few
of its kind whose operations have been consistently sup-
ported by long-term public funding. The incidence rate
of malignant and benign tumours was about 800 and
900 cases per 100,000 dog-years at risk, respectively,
with the largest impact on females and purebred dogs.
The highest incidence rates by sex and tumour site were
observed for mammary and cutaneous tissues in females
and cutaneous tissues and testicles in males. These re-
sults were obtained by paying particular attention to the
validity of the data collection process, thus minimizing
the potential for bias.
Given the constraints derived from working with a ca-
nine population, considerable effort was expended to es-
timate the relevant denominators in terms of population
size and structure. Moreover, we were able to obtain de-
tailed reports of cases of incidental tumours by selecting
a small-medium size catchment area and through public
awareness campaigns coupled with enhanced participa-
tion of veterinary practices offered scientific support and
histological examinations free of charge.
Fig. 2 Population age structure by sex. Age structure of the study
population, by sex
Fig. 3 Number of cases by tumour site. Number of tumours collected during the study period, by tumour site
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Though our study may have limitations, they do not
necessarily compromise its internal or external validity.
By mobilizing the available human and economic re-
sources and restricting the cancer registration to a
relatively small area (canine population of about
10,000 units), we were able to maintain the activities for
a 90-month period, with a total of about 70,000 dog-
years at risk which were then used as the overall denom-
inator. The resulting overall incidence rates were found
to be stable; however, less precise estimates could also
have been obtained by looking at subgroups (e.g., muni-
cipality, breed, age class). For this reason, we carried out
few subgroups analyses within our dataset.
As mentioned, there remains the potential for some
residual bias in the quantification of the denominators
and the numerators. Selection bias is less likely to be a
problem with population-based registries than, for ex-
ample, hospital-based registries [18, 19] or canine
registries using databases from pet insurance companies
where cross-breed dogs or aged dogs are apt to be un-
derrepresented [6, 20].
With regard to the capture-recapture strategy that was
applied to estimate the unknown canine population size,
some of the assumptions this approach [14] requires
may not have been fully met, e.g., working on a closed
population and using random samples (assumptions that
are unlikely to be met in a field situation); however,
there are no evident reasons that preclude that the re-
cruited dogs were equally likely to be captured in each
of the two samples. The midterm census of 44 of the 46
municipalities in the catchment area indicated no large
deviation from the direct enumeration of the existent
dogs.
Additionally the population structure by breed- or
age-strata may not be as precise as the population size.
The structure was obtained from our second capture
(the anonymous questionnaire survey) only. Unfortu-
nately, the data on the first capture (i.e., the canine iden-
tification and registration system) and the midterm
census were available only in hard copy format, preclud-
ing any practical way to further analyse the data. There-
fore, the incidence rates are likely to be more robust
when the denominator was the entire population (e.g.,
crude malignant rate or site-specific rates) rather than
when the denominators referred to individual breeds or
age classes.
Finally, with regard to the cases of incidental tumours,
a certain degree of underdetection may have occurred.
In particular, a proportion of tumours may have gone
undiagnosed (e.g., a deep organ tumour), or not reported
as not requiring histological confirmation (e.g., osteosar-
coma, lymphoma) or may have been diagnosed by la-
boratories other than ours and not reported by the
collaborating veterinary practitioners. In an attempt to
minimize these problems, the collaborating veterinary
practitioners were given standardized case report forms
and local laboratories were contacted.
Assuming an unbiased estimation of cancer occur-
rence, the incidence rates in our registry are higher than
those reported by similar population-based registries in
Italy [12, 13] where the crude incidence rates for all ma-
lignant cancer were less than 200 cases per 100,000 dog-
years at risk. The differences, albeit evident, are smaller
when the comparison is carried out with data from
international population-based registries ([7, 8, 21]).
Rates higher than ours were reported in a registry that
used as a denominator for cancer incidence all dogs in-
sured with a pet U.K. insurance company [4]. The higher
cancer rates we found cannot be convincingly linked to
exposure of the dogs to as yet undetected environmental
risk factors in the catchment area. Instead, the excess in-
cidence may more likely stem from the effect of a
Table 1 Crude incidence rates
Number of cases Dog-years IR 95% CI
Crude 554 68,865 804 739–874
Female 344 31,113 1106 992–1229
Male 209 37,748 554 481–634
Purebred 311 32,820 948 845–1059
Crossbreed 233 36,045 646 566–735
Period 1 151 17,599 858 727–1006
Period 2 403 51,266 786 711–867
Malignant tumour incidence rates by sex, breed, and calendar period (cases
per 100,000 dog-years at risk). CI denotes confidence interval, IR incidence rate
Table 2 Breeds
Breed Number of
cases
Dog-years IR 95% CI
Yorkshire terrier 19 555 3423 2061–5346
Boxer 34 1223 2781 1925–3885
Alaskan malamute 3 113 2667 548–7759
Chow chow 3 113 2667 548–7759
Pinscher 7 443 1582 635–3256
Dalmatian 5 338 1481 480–3452
English cocker spaniel 9 668 1348 616–2558
Italian pointer 3 225 1333 275–3897
Siberian husky 14 1223 1145 626–1921
Rottweiler 10 893 1120 537–2059
English setter 13 1335 974 519–1665
German shepherd dog 71 7785 912 712–1150
Malignant tumour incidence rates in the most common breeds in the study
population (cases per 100,000 dog-years at risk). CI denotes confidence
interval, IR incidence rate. Breeds with incidence rates below 900 cases per
100,000 dog-years at risk not shown
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different distribution of confounding factors such as age
and breed, which are known determinants of cancer in
dogs [22–24]. Unfortunately, in most of the comparable
studies, data on the population structure by age and
breed were not available, preventing any appropriate
comparison of rates. Moreover unlike other studies, in
ours the denominators were reduced to take into ac-
count the real proportion of dogs under veterinary care,
an adjustment not reported elsewhere.
Another explanation for the high cancer rates we
found may be due to the way we managed the data on
multiple primary tumours, which are a common finding
in dogs [25–27]. Based on the histopathological diagno-
sis, each type of neoplasm was classified as a separate
cancer and added to the numerator. Other canine regis-
tries may not have done this. Finally, the potential risk
of overestimation due to the inclusion of cases sourced
from outside the registry catchment area was minimized
by applying the preliminary case inclusion/exclusion cri-
teria established in the registration protocol.
The distribution of cancer types in our registry is
fairly consistent with the literature. As reported else-
where [7–13, 21], the most prevalent malignant neo-
plasms were mammary carcinoma and cutaneous
mastocytoma. The high prevalence of seminoma found
in the Norwegian dog population [22] is analogous to
the high incidence estimated in our registry. With re-
gard to breed, the higher incidence rates in purebred
rather than in cross-breed dogs were evident for
Yorkshire terrier and Boxer, breeds known [5, 7, 27]
to be particularly at risk of developing neoplasms, for
which a genetic predisposition has been suggested. In
the female dogs, the observed cancer trend by age
matches those seen in other studies, with an exponen-
tial increase in elderly females for all tumours [9] or
specifically for mammary tumours [5].
Comparison with the recent findings from two other
Italian cancer registries [12, 13] shows that the distribu-
tion of tumours is substantially similar. In our registry,
the ratio of malignant to benign tumours was 0.90:1, as
compared to 0.96:1 in Genoa and 1:1 in the Veneto
Region. The incidence of malignant cancer was higher in
females than in males (2.5 times, 2.7 times, and 1.7 times
in the study area, Genoa, and Veneto, respectively) and
in purebred dogs than in cross-breed dogs (1.5 times in
Piedmont and 2 times in Veneto where data were avail-
able). Finally, the distribution by tumour site (mammary
and cutaneous/soft tissues tumours in females and
cutaneous/soft tissues and genital tract tumours in
males) was quite similar for all three registries. The ex-
ceptionally higher incidence of lymphoma in dogs of
both sexes in the Genoa registry may have been due to
Fig. 4 Age and sex-specific incidence rates. Age and sex specific incidence rates: cases per 100,000 dog-years at risk
Fig. 5 Malignant tumours: site- and sex-specific incidence rates. Site
and sex specific incidence rates for malignant tumours: cases per
100,000 dog-years at risk
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the inclusion of cancers diagnosed by cytology or be-
cause of exposure to unknown risk factors present in a
large city.
The Piedmont canine cancer registry is based on a
large target population that combine rural and urban
environments and on a population-based study de-
sign; for this reason our findings have the necessary
external validity to be generalized, after adjustment
for breed and age, to the canine population of north-
western Italy.
Assuming that the incidence rates from a population-
based registry have external validity, national and inter-
national standards should be developed and shared to be
able to make any meaningful comparison across studies.
The adoption of an international classification and cod-
ing system, like the International Classification of
Diseases for Oncology used in human cancer registries
[28], would facilitate the exchange of comparable data
and the possibility to carry out multicenter studies [29].
Finally, basic epidemiological methods (e.g.,
standardization techniques) to account for the con-
founding effect of age and breed should always be
applied: data on population structure should be col-
lected and made available in each study and, as pro-
posed by Thrusfield [30], an international normal dog
population should be established and shared as an ex-
ternal standard.
Conclusions
As highlighted by Kelsey et al. [19], the data from
population-based canine cancer registries may facilitate
the identification of a less select group of cases for case-
control studies and allow examination of trends over
time and geographic differences in cancer incidence.
The findings from the current study provide data on the
incidence of canine tumours. The incidence rates may
be useful for assessing the impact of neoplastic diseases
in the canine population in northwestern Italy and may
serve as a reference when setting up studies to detect ex-
cess risks in the incidence of malignant tumours in dogs
used as sentinels for community exposure to environ-
mental carcinogens.
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